By using CHX treatment, we confirmed that GAS5 negatively regulated the level of TRIB3 protein by promoting TRIB3 protein ubiquitination and subsequent degradation in NSCLC cells. The gene discussed is GAS5; the disease is non-small cell lung carcinoma.